Advertisement

Topics

European Medicines Evaluation Agency (EMEA) Company Profile

16:43 EST 18th November 2017 | BioPortfolio

European Medicines Evaluation Agency (EMEA)

Location

7 Westferry Circus
Canary Wharf
London
E14 4H
United Kingdom

Contact

Phone: +44 (0)20 74188400
Fax: +44 (0)20 74188416
Email: mail@emea.eudra.org


News Articles [2195 Associated News Articles listed on BioPortfolio]

PharmaMar Submits the Marketing Authorisation Application for Aplidin® in Switzerland

MADRID, October 4, 2017 /PRNewswire/ -- Pharma Mar S.A. submitted the Marketing Authorisation Application in the European Union at the end of 2016 The regulatory process for oncologi...

Spain hires more staff at drug agency to prepare for Brexit disruption

MADRID (Reuters) - Spain posted 40 vacancies at its National Drug Agency on Wednesday to reinforce evaluation and monitoring of medicines ahead of Britain's exit from the European Union which will lik...

Pharma fears politics will sway choice of new European Medicines Agency home

There is just a week to go before the remaining EU27 countries vote on which city should be the new home of the European Medicines Agency, which must leave London because of Brexit. No fewer than 19 ...

Pulled From EU Assessment Process: Orphan Drugs For Kidney Disease, Mesothelioma

Two orphan medicines have been withdrawn from the evaluation process at the European Medicines Agency, one of them for recurrent...   

Germany eyes European Medicines Agency after Brexit

Germany said Wednesday it would apply for the European Medicines Agency (EMA) to move from London to Bonn after Brexit, pitting the western city against EU competitors from Helsinki to Barcelona.

European Medicines Agency reveals favoured cities for relocation

The European Medicines Agency has revealed a list of five cities that are preferred as its new location by staff after Brexit, following warnings of a public health disaster if EU leaders pick the wro...

Roche's Tecentriq receives positive opinion from EU medicines agency

ZURICH (Reuters) - A European Medicines Agency (EMA) panel said on Friday it has recommended Roche's immunotherapy Tecentriq as a treatment for advanced bladder and lung cancer, setting the stage for ...

How the EU regulates medicines

The European Medicines Agency (EMA) will host an awareness session to present the European Union’s (EU) medicines regulatory system and EMA's role in it to international regulators and non-governmen...

Drugs and Medications [186 Associated Drugs and Medications listed on BioPortfolio]

Terbinafine hydrochloride [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use terbinafine hydrochloride safely and effectively. See full prescribing information for terbinafine hydrochloride tablets.Terbinafine H...

Cimetidine [Walgreen Company]

Walgreen Co. Cimetidine 200 Drug Facts

Dg health heartburn relief [Dolgencorp, LLC]

Dolgencorp, LLC Heartburn Relief Drug Facts

Acid reducer [Rite Aid Corporation]

Rite Aid Corporation Acid Reducer Drug Facts

Smart sense acid reducer [Kmart Corporation]

Kmart Corporation Acid Reducer Drug Facts

PubMed Articles [3072 Associated PubMed Articles listed on BioPortfolio]

RUMA adopts European Medicines Agency's list of highest priority antibiotics.

TRANSPARENCY POLICIES OF THE EUROPEAN MEDICINES AGENCY: HAS THE PARADIGM SHIFTED?

This article reflects on the state of play as regards access to non-summary clinical trial data in the European Union (EU). In particular, it examines the scope of access under the recent transparency...

Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalence.

The European Medicines Agency (EMA) requires that a specific valved holding chamber (VHC) is designated for use with a given pressurised metered dose inhaler (pMDI). No other regulatory authorities im...

Forced degradation of recombinant monoclonal antibodies: a practical guide.

Forced degradation studies have become integral to the development of recombinant monoclonal antibody therapeutics by serving a variety of objectives from early stage manufacturability evaluation to s...

Impaired self-agency inferences in schizophrenia: The role of cognitive capacity and causal reasoning style.

The sense of self-agency, i.e., experiencing oneself as the cause of one's own actions, is impaired in patients with schizophrenia. Normally, inferences of self-agency are enhanced when actual outcome...

Clinical Trials [1950 Associated Clinical Trials listed on BioPortfolio]

Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

The focus of this study is to assess the safety of GSK's H1N1 vaccine in real life conditions as soon as the vaccine is used, in a mass vaccination programme, and with a system for rapid g...

PENTA Fosamprenavir Study

Twice daily fosamprenavir, in combination with low dose ritonavir (FPV/RTV BID), is indicated for the treatment of HIV-infected adults, adolescents and children of 6 years of age and above...

A Non-interventional Study to Identify the Patients With Severe Luteinizing Hormone Deficiency in the Daily Practice

This non-interventional study is planned to identify the subjects with severe luteinizing hormone (LH) deficiency in the daily practice. The results will be used for the "Periodic Safety U...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

This study is to identify the preferred vaccine dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in healthy children...

Companies [1820 Associated Companies listed on BioPortfolio]

European Medicines Agency

European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London.ts main responsibility is the protection and promotion of public and animal health, through t...

European Medicines Evaluation Agency (EMEA)

European Medicines Evaluation Agency (EMEA)

European Generic medicines Association

The EGA is the official representative body of the European generic pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans and stimu...

European Directorate for the Quality of Medicines

The EDQM was created in 1996 and is a Directorate of the Council of Europe. Its premises have been especially designed for its various activities. Today the EDQM is organised into nine administrative...

Australia New ZealandTherapeutic ProductsAuthority

The trans Tasman therapeutic products agency project has involved New Zealand and Australia giving consideration to establishing a joint agency to regulate therapeutic products (medicines, medical dev...

More Information about "European Medicines Evaluation Agency (EMEA)" on BioPortfolio

We have published hundreds of European Medicines Evaluation Agency (EMEA) news stories on BioPortfolio along with dozens of European Medicines Evaluation Agency (EMEA) Clinical Trials and PubMed Articles about European Medicines Evaluation Agency (EMEA) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Medicines Evaluation Agency (EMEA) Companies in our database. You can also find out about relevant European Medicines Evaluation Agency (EMEA) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record